Cargando…
CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling
CD44, a cell adhesion protein, involves in various process in cancer such as cell survival and metastasis. Most researches on CD44 in cancer focus on cancer cells. Recently, it is found that CD44 expression is high in fibroblasts of tumour microenvironment. However, its role in communication between...
Autores principales: | Liu, Yonglei, Yu, Conghui, Wu, Yonggang, Sun, Xiangjun, Su, Quanping, You, Cuiping, Xin, Hongwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571562/ https://www.ncbi.nlm.nih.gov/pubmed/28523716 http://dx.doi.org/10.1111/jcmm.13118 |
Ejemplares similares
-
Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer
por: Liu, Yonglei, et al.
Publicado: (2017) -
CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502–5p/KRAS and IGF2BP2/Myc axes
por: Li, Jie, et al.
Publicado: (2021) -
CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014) -
TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis
por: Yang, Ruotong, et al.
Publicado: (2023) -
Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)